These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 18217313

  • 1. [Chronic eosinophilic pneumonia complicated by bronchial asthma and diabetes mellitus successfully treated with suplatast tosilate and high-dose inhaled corticosteroid therapy].
    Fujimori K, Shimatsu Y, Suzuki E, Arakawa M, Gejyo F.
    Nihon Kokyuki Gakkai Zasshi; 1999 Nov; 37(11):903-8. PubMed ID: 18217313
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Chronic eosinophilic pneumonia successfully treated with suplatast tosilate].
    Hamada H, Sakatani M, Nishioka M, Akira M, Yamamoto S, Ueda E, Okano Y, Nakamura Y, Sone S.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Jun; 35(6):692-7. PubMed ID: 9294307
    [Abstract] [Full Text] [Related]

  • 4. [Levofloxacin-induced eosinophilic pneumonia complicated by bronchial asthma].
    Fujimori K, Shimatsu Y, Suzuki E, Arakawa M, Gejyo F.
    Nihon Kokyuki Gakkai Zasshi; 2000 May; 38(5):385-90. PubMed ID: 10921286
    [Abstract] [Full Text] [Related]

  • 5. A case of eosinophilic pneumonia successfully treated with suplatast tosilate alone.
    Watanabe N, Hirata A, Makino S, Fukuda T.
    Int Arch Allergy Immunol; 2009 May; 149 Suppl 1():94-101. PubMed ID: 19494513
    [Abstract] [Full Text] [Related]

  • 6. Add-on effects of suplatast tosilate in bronchial asthma patients treated with inhaled corticosteroids.
    Sano T, Nakamura Y, Yanagawa H, Bando H, Nii A, Yoshida S, Sone S, Higashishikoku Asthma Research Group.
    Lung; 2003 May; 181(4):227-35. PubMed ID: 14692563
    [Abstract] [Full Text] [Related]

  • 7. Effect of suplatast tosilate, a Th2 cytokine inhibitor, on steroid-dependent asthma: a double-blind randomised study. Tokyo Joshi-Idai Asthma Research Group.
    Tamaoki J, Kondo M, Sakai N, Aoshiba K, Tagaya E, Nakata J, Isono K, Nagai A.
    Lancet; 2000 Jul 22; 356(9226):273-8. PubMed ID: 11071181
    [Abstract] [Full Text] [Related]

  • 8. Suplatast tosilate alters DC1/DC2 balance in peripheral blood in bronchial asthma.
    Yokomura K, Suda T, Matsuda H, Hashizume H, Asada K, Suzuki K, Chida K.
    J Asthma; 2005 Sep 22; 42(7):567-70. PubMed ID: 16169790
    [Abstract] [Full Text] [Related]

  • 9. Effect of suplatast tosilate, a Th2 cytokine inhibitor, on cough variant asthma.
    Shioya T, Satake M, Sano M, Kagaya M, Watanabe A, Sato K, Ito T, Ito N, Sasaki M, Miura M.
    Eur J Clin Pharmacol; 2002 Jun 22; 58(3):171-6. PubMed ID: 12107601
    [Abstract] [Full Text] [Related]

  • 10. Effect of suplatast tosilate on goblet cell metaplasia in patients with asthma.
    Hoshino M, Fujita Y, Saji J, Inoue T, Nakagawa T, Miyazawa T.
    Allergy; 2005 Nov 22; 60(11):1394-400. PubMed ID: 16197471
    [Abstract] [Full Text] [Related]

  • 11. [Anti-inflammatory drugs for the treatment of bronchial hyperresponsiveness].
    Sano Y.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec 22; 34 Suppl():48-53. PubMed ID: 9216184
    [Abstract] [Full Text] [Related]

  • 12. Effects of suplatast tosilate on airway inflammation and airway hyperresponsiveness.
    Horiguchi T, Tachikawa S, Handa M, Hanazono K, Kondo R, Ishibashi A, Banno K.
    J Asthma; 2001 Jun 22; 38(4):331-6. PubMed ID: 11456386
    [Abstract] [Full Text] [Related]

  • 13. [A case report of eosinophilic cystitis treated with oral suplatast tosilate].
    Kuramoto T, Senzaki H, Inagaki T.
    Hinyokika Kiyo; 2014 Sep 22; 60(9):447-50. PubMed ID: 25293800
    [Abstract] [Full Text] [Related]

  • 14. Effects of suplatast tosilate on allergic eosinophilic airway inflammation in patients with mild asthma.
    Sano Y, Suzuki N, Yamada H, To Y, Ogawa C, Ohta K, Adachi M.
    J Allergy Clin Immunol; 2003 May 22; 111(5):958-66. PubMed ID: 12743558
    [Abstract] [Full Text] [Related]

  • 15. Effect of suplatast tosilate on airway hyperresponsiveness and inflammation in asthma patients.
    Yoshida M, Aizawa H, Inoue H, Matsumoto K, Koto H, Komori M, Fukuyama S, Okamoto M, Hara N.
    J Asthma; 2002 Sep 22; 39(6):545-52. PubMed ID: 12375715
    [Abstract] [Full Text] [Related]

  • 16. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
    Woerly G, Decot V, Loiseau S, Loyens M, Chihara J, Ono N, Capron M.
    Clin Exp Allergy; 2004 Sep 22; 34(9):1379-87. PubMed ID: 15347370
    [Abstract] [Full Text] [Related]

  • 17. Effect of an orally active Th2 cytokine inhibitor, suplatast on "atopic cough" tosilate.
    Ishiura Y, Fujimura M, Yamamoto H, Nobata K, Ishiguro T, Ogawa H, Myou S.
    Arzneimittelforschung; 2008 Sep 22; 58(6):297-302. PubMed ID: 18677972
    [Abstract] [Full Text] [Related]

  • 18. Inhibitory effects of suplatast tosilate on the differentiation and function of monocyte-derived dendritic cells from patients with asthma.
    Tanaka A, Minoguchi K, Samson KT, Oda N, Yokoe T, Tazaki T, Yamamoto Y, Yamamoto M, Ohta S, Adachi M.
    Clin Exp Allergy; 2007 Jul 22; 37(7):1083-9. PubMed ID: 17581203
    [Abstract] [Full Text] [Related]

  • 19. [A case of eosinophilic cystitis that was treated with oral suplatast tosilate (IPD-1151T)].
    Watanabe M, Yamaguchi K, Yamanishi T, Kamai T, Yoshida K.
    Hinyokika Kiyo; 2009 Nov 22; 55(11):715-9. PubMed ID: 19946192
    [Abstract] [Full Text] [Related]

  • 20. Chronic eosinophilic pneumonia: a case report.
    Phunmanee A, Boonsawat W, Charoensiri DJ, Limkunacul C.
    J Med Assoc Thai; 2000 Aug 22; 83(8):959-63. PubMed ID: 10998853
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.